Icrucumab ELISA Kit
Product Specifications
Background
Icrucumab (IMC-18F1), a human monoclonal antibody against vascular endothelial growth factor receptor-1 (VEGFR-1), potently inhibits ligand-dependent phosphorylation of VEGFR-1 and downstream signaling, making icrucumab an attractive candidate for antitumor activity.
Specifications
Icrucumab
Product Name Alternative
18F1, IMC-18F1, LY3012212, CAS: 1024603-92-6
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742876-500 1x 500 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (C31/2876R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B690930-250MG 250 mg
1-(4-tert-Butylphenyl)-4-chloro-1-butanone
Sign In for Pricing
View Details 
